HK1138581A1 - Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands - Google Patents

Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands

Info

Publication number: HK1138581A1
Authority: HK; Hong Kong
Prior art keywords: quinolines; triazolo; adenosine; receptor ligands; ligands
Prior art date: 2007-06-07

Application number

HK10104249.9A

Other languages

English (en)

Inventor

Edit Susan

Kinga Boer

Zoltan Kapui

Geza Timari

Sandor Batori

Zoltan Szlavik

Endre Mikus

Szeredi Judit Vargane

Michel Finet

Szabo Katalin Urban

Tibor Szabo

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-07

Filing date

2010-04-29

Publication date

2010-08-27

2010-04-29 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2010-08-27 Publication of HK1138581A1 publication Critical patent/HK1138581A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)

HK10104249.9A 2007-06-07 2010-04-29 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands HK1138581A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0700395A HUP0700395A2 (en)	2007-06-07	2007-06-07	Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
PCT/HU2008/000063 WO2008149168A1 (en)	2007-06-07	2008-06-02	Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands

Publications (1)

Publication Number	Publication Date
HK1138581A1 true HK1138581A1 (en)	2010-08-27

Family

ID=89987565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK10104249.9A HK1138581A1 (en)	2007-06-07	2010-04-29	Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands

Country Status (45)

Country	Link
US (1)	US8338411B2 (es)
EP (1)	EP2167470B1 (es)
JP (1)	JP5487100B2 (es)
KR (1)	KR20100031610A (es)
CN (1)	CN101679272B (es)
AR (1)	AR066873A1 (es)
AT (1)	ATE502016T1 (es)
AU (1)	AU2008259534B2 (es)
BR (1)	BRPI0812257A2 (es)
CA (1)	CA2689612A1 (es)
CL (1)	CL2008001648A1 (es)
CO (1)	CO6270233A2 (es)
CR (1)	CR11171A (es)
CY (1)	CY1111644T1 (es)
DE (1)	DE602008005589D1 (es)
DK (1)	DK2167470T3 (es)
DO (1)	DOP2009000276A (es)
EC (1)	ECSP099783A (es)
ES (1)	ES2363672T3 (es)
GT (1)	GT200900301A (es)
HK (1)	HK1138581A1 (es)
HN (1)	HN2009003357A (es)
HR (1)	HRP20110332T1 (es)
HU (1)	HUP0700395A2 (es)
IL (1)	IL202471A0 (es)
JO (1)	JO2689B1 (es)
MA (1)	MA31738B1 (es)
ME (1)	ME00958B (es)
MX (1)	MX2009013209A (es)
MY (1)	MY148654A (es)
NI (1)	NI200900210A (es)
NZ (1)	NZ581186A (es)
PA (1)	PA8782901A1 (es)
PE (1)	PE20090325A1 (es)
PL (1)	PL2167470T3 (es)
PT (1)	PT2167470E (es)
RU (1)	RU2489432C2 (es)
SI (1)	SI2167470T1 (es)
SV (1)	SV2009003420A (es)
TN (1)	TN2009000482A1 (es)
TW (1)	TWI424998B (es)
UA (1)	UA99463C2 (es)
UY (1)	UY31130A1 (es)
WO (1)	WO2008149168A1 (es)
ZA (1)	ZA200908280B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5753844B2 (ja)	2009-07-08	2015-07-22	ダーミラ（カナダ），インコーポレーテッド	皮膚疾患または病変の治療に有用なｔｏｆａ類似体
FR3053968A1 (fr) *	2016-07-13	2018-01-19	Biomerieux	Reactifs pour la protection reversible de molecules biologiques
CU24569B1 (es)	2016-09-24	2022-01-13	Kbp Biosciences Co Ltd	Composición farmacéutica como antagonista del receptor de mineralocorticoides
PE20211001A1 (es)	2018-02-27	2021-06-01	Incyte Corp	Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b
US11168089B2 (en)	2018-05-18	2021-11-09	Incyte Corporation	Fused pyrimidine derivatives as A2A / A2B inhibitors
MA53097A (fr)	2018-07-05	2021-05-12	Incyte Corp	Dérivés de pyrazine fusionnés en tant qu'inhibiteurs d'a2a/a2b
CR20210271A (es)	2018-11-30	2021-07-14	Merck Sharp & Dohme	Derivados de amino triazolo quinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmacéuticas y su uso
PE20220277A1 (es)	2018-12-20	2022-02-25	Incyte Corp	Compuestos de imidazopiridazina e imidazopiridina como inhibidores de quinasa-2 de tipo receptor de activina
TWI829857B (zh)	2019-01-29	2024-01-21	美商英塞特公司	作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1479759A (en) *	1974-11-23	1977-07-13	Lepetit Spa	Heterocyclic fused derivatives of indole and quinoline
GR76063B (es) *	1981-04-03	1984-08-03	Roussel Uclaf
ZA836701B (en) *	1982-10-01	1984-10-31	Roussel Uclaf	Imidazo(1,2-a)quinolines
GB0108475D0 (en)	2001-04-04	2001-05-23	Merck Sharp & Dohme	New compounds
AU2002304358B2 (en) *	2001-05-31	2007-08-23	Sanofi-Aventis	Aminoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands
US6514989B1 (en)	2001-07-20	2003-02-04	Hoffmann-La Roche Inc.	Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
US20050107611A1 (en)	2001-12-21	2005-05-19	Barbara Matuszczak	Pyrazolyl-substituted triazoloquinoxalines
HUP0105407A3 (en) *	2001-12-21	2004-04-28	Sanofi Aventis	Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0105406A3 (en) *	2001-12-21	2003-12-29	Sanofi Aventis	Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0203976A3 (en) *	2002-11-15	2004-08-30	Sanofi Aventis	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
DE602004010284T2 (de) *	2003-07-31	2008-10-02	Sanofi-Aventis	Aminochinolinderivate und deren verwendung als adenosin-a3-liganden

2007
- 2007-06-07 HU HU0700395A patent/HUP0700395A2/hu unknown
2008
- 2008-02-06 UA UAA200913976A patent/UA99463C2/ru unknown
- 2008-06-02 EP EP08762666A patent/EP2167470B1/en active Active
- 2008-06-02 DK DK08762666.9T patent/DK2167470T3/da active
- 2008-06-02 NZ NZ581186A patent/NZ581186A/en not_active IP Right Cessation
- 2008-06-02 JP JP2010510891A patent/JP5487100B2/ja not_active Expired - Fee Related
- 2008-06-02 BR BRPI0812257-1A2A patent/BRPI0812257A2/pt not_active IP Right Cessation
- 2008-06-02 KR KR1020107000342A patent/KR20100031610A/ko not_active Application Discontinuation
- 2008-06-02 PL PL08762666T patent/PL2167470T3/pl unknown
- 2008-06-02 PT PT08762666T patent/PT2167470E/pt unknown
- 2008-06-02 CA CA002689612A patent/CA2689612A1/en not_active Abandoned
- 2008-06-02 ME MEP-2009-340A patent/ME00958B/me unknown
- 2008-06-02 AT AT08762666T patent/ATE502016T1/de active
- 2008-06-02 WO PCT/HU2008/000063 patent/WO2008149168A1/en active Application Filing
- 2008-06-02 SI SI200830255T patent/SI2167470T1/sl unknown
- 2008-06-02 AU AU2008259534A patent/AU2008259534B2/en not_active Ceased
- 2008-06-02 RU RU2009149518/04A patent/RU2489432C2/ru not_active IP Right Cessation
- 2008-06-02 DE DE602008005589T patent/DE602008005589D1/de active Active
- 2008-06-02 MX MX2009013209A patent/MX2009013209A/es active IP Right Grant
- 2008-06-02 ES ES08762666T patent/ES2363672T3/es active Active
- 2008-06-02 MY MYPI20095180A patent/MY148654A/en unknown
- 2008-06-02 CN CN2008800191923A patent/CN101679272B/zh not_active Expired - Fee Related
- 2008-06-05 PE PE2008000960A patent/PE20090325A1/es not_active Application Discontinuation
- 2008-06-05 JO JO2008263A patent/JO2689B1/en active
- 2008-06-05 AR ARP080102391A patent/AR066873A1/es not_active Application Discontinuation
- 2008-06-05 PA PA20088782901A patent/PA8782901A1/es unknown
- 2008-06-05 CL CL200801648A patent/CL2008001648A1/es unknown
- 2008-06-06 UY UY31130A patent/UY31130A1/es not_active Application Discontinuation
- 2008-06-06 TW TW097121025A patent/TWI424998B/zh not_active IP Right Cessation
2009
- 2009-11-13 TN TNP2009000482A patent/TN2009000482A1/fr unknown
- 2009-11-20 GT GT200900301A patent/GT200900301A/es unknown
- 2009-11-23 ZA ZA2009/08280A patent/ZA200908280B/en unknown
- 2009-11-24 SV SV2009003420A patent/SV2009003420A/es unknown
- 2009-12-02 IL IL202471A patent/IL202471A0/en unknown
- 2009-12-03 NI NI200900210A patent/NI200900210A/es unknown
- 2009-12-04 DO DO2009000276A patent/DOP2009000276A/es unknown
- 2009-12-04 EC EC2009009783A patent/ECSP099783A/es unknown
- 2009-12-04 US US12/631,139 patent/US8338411B2/en active Active
- 2009-12-04 HN HN2009003357A patent/HN2009003357A/es unknown
- 2009-12-16 CR CR11171A patent/CR11171A/es unknown
2010
- 2010-01-06 CO CO10001036A patent/CO6270233A2/es active IP Right Grant
- 2010-01-07 MA MA32498A patent/MA31738B1/fr unknown
- 2010-04-29 HK HK10104249.9A patent/HK1138581A1/xx not_active IP Right Cessation
2011
- 2011-05-06 HR HR20110332T patent/HRP20110332T1/hr unknown
- 2011-05-30 CY CY20111100519T patent/CY1111644T1/el unknown

Also Published As

Publication number	Publication date
TW200914451A (en)	2009-04-01
NI200900210A (es)	2010-07-15
MX2009013209A (es)	2010-04-09
WO2008149168A8 (en)	2010-01-07
SV2009003420A (es)	2010-04-26
US20100216786A1 (en)	2010-08-26
DOP2009000276A (es)	2010-01-31
CR11171A (es)	2010-04-21
MA31738B1 (fr)	2010-10-01
CY1111644T1 (el)	2015-10-07
HN2009003357A (es)	2013-08-12
CO6270233A2 (es)	2011-04-20
EP2167470A1 (en)	2010-03-31
AU2008259534A1 (en)	2008-12-11
AR066873A1 (es)	2009-09-16
CA2689612A1 (en)	2008-12-11
JO2689B1 (en)	2013-03-03
PE20090325A1 (es)	2009-04-17
NZ581186A (en)	2012-03-30
UY31130A1 (es)	2009-01-30
PA8782901A1 (es)	2009-01-23
UA99463C2 (en)	2012-08-27
DK2167470T3 (da)	2011-06-27
HRP20110332T1 (hr)	2011-06-30
JP5487100B2 (ja)	2014-05-07
CN101679272A (zh)	2010-03-24
WO2008149168A1 (en)	2008-12-11
ATE502016T1 (de)	2011-04-15
CL2008001648A1 (es)	2008-10-10
DE602008005589D1 (de)	2011-04-28
HU0700395D0 (en)	2007-07-30
TWI424998B (zh)	2014-02-01
GT200900301A (es)	2010-04-22
HUP0700395A2 (en)	2009-03-02
US8338411B2 (en)	2012-12-25
KR20100031610A (ko)	2010-03-23
JP2010529100A (ja)	2010-08-26
IL202471A0 (en)	2010-06-30
TN2009000482A1 (en)	2011-03-31
ECSP099783A (es)	2010-01-29
RU2489432C2 (ru)	2013-08-10
SI2167470T1 (sl)	2011-06-30
MY148654A (en)	2013-05-15
EP2167470B1 (en)	2011-03-16
RU2009149518A (ru)	2011-07-20
CN101679272B (zh)	2013-02-06
PT2167470E (pt)	2011-05-16
ZA200908280B (en)	2010-07-28
ME00958B (me)	2012-06-20
AU2008259534B2 (en)	2012-07-05
ES2363672T3 (es)	2011-08-11
BRPI0812257A2 (pt)	2014-12-23
PL2167470T3 (pl)	2011-08-31

Publication	Publication Date	Title
ZA201101701B (en)	2012-05-30	Pyrrolo[2,3-d]pyrimidine compounds
HK1138581A1 (en)	2010-08-27	Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands
ZA201202718B (en)	2012-12-27	Pyrrolo[2,3-d]pyrimidine compounds
PT2217578E (pt)	2014-02-17	Compostos de [1,2,4]triazolo[1,5-a]piridina e [1,2,4]triazolo[1,5-c]pirimidina e a sua utilização
ZA201002318B (en)	2012-09-26	Pyrrolo [2,3-d]pyrimidin derivatives as protein kinase b inhibitors
HRP20130660T1 (en)	2013-08-31	Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
BRPI0822237A2 (pt)	2015-06-30	Compostos de imidazo [1,2-a] piridina
ZA200805354B (en)	2009-10-28	Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives
IL206811A0 (en)	2010-12-30	NOVEL PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AS ANTI-CANCER AGENTS
ZA201004368B (en)	2013-01-30	Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
PL2124944T3 (pl)	2012-08-31	Pochodne pirazolo[3,4-b]pirydyny jako inhibitory fosfodiesterazy
AU2008313789A8 (en)	2010-04-29	Purine derivatives as adenosine AL receptor ligands
EP2142542A4 (en)	2011-06-22	NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704
PL2155712T3 (pl)	2017-02-28	3-(imidazolilo)-pirazolo[3,4-b]pirydyny
BRPI0822239A2 (pt)	2015-06-30	Composto de pirazolo[1,5-a] pirimidina
ZA200907416B (en)	2010-07-28	Pyrimido [4,5-D] azepine derivatives as 5-HT2C agonists
SI1899343T1 (sl)	2010-09-30	Halogenirani pirazolo a pirimidini postopkiuporabe kot ligand receptorjev GABA A sestavki in intermediati
EP2511276A4 (en)	2012-12-19	PYRROLO [2,3-D] PYRIMIDINE DERIVATIVE
IL206666A0 (en)	2010-12-30	N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
IL188924A0 (en)	2008-08-07	Imidazopyridine derivatives as cannabinoid receptor ligands
IL206668A0 (en)	2010-12-30	N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
ZA200800354B (en)	2008-12-31	Imidazopyridine derivatives as cannabinoid receptor ligands
IL194384A0 (en)	2009-08-03	Process for preparaing 6,7-dihydro-5h-imidazo[1,5-a]pyridin-8-one

Legal Events

Date	Code	Title	Description
2015-12-24	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20150602